Activity of RX-P873, a novel pyrrolocytosine, against Gram-negative bacteria

Int J Antimicrob Agents. 2015 Sep;46(3):352-4. doi: 10.1016/j.ijantimicag.2015.06.001. Epub 2015 Jun 19.

Authors

I Morrissey¹, S Magnet², E Genet², P Jeandey², A Marra³, S Hawser², E Duffy³

Affiliations

¹ IHMA Europe Sàrl, 9A route de la Corniche, Epalinges 1066, Switzerland. Electronic address: [email protected].
² IHMA Europe Sàrl, 9A route de la Corniche, Epalinges 1066, Switzerland.
³ Melinta Therapeutics, New Haven, CT, USA.

PMID: 26159867
DOI: 10.1016/j.ijantimicag.2015.06.001

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / pharmacology*
Gram-Negative Bacteria / drug effects*
Guanidines / pharmacology*
Humans
Microbial Sensitivity Tests
Pyrimidinones / pharmacology*

Substances

Anti-Bacterial Agents
Guanidines
Pyrimidinones
RX-P873